Infectious clone methodology is a valuable tool of modern experimental virology. However, its use is often constrained by the instability of infectious clone constructs during propagation in E. coli. To circumvent this problem, we have devised a strategy that could be suitable for design of (ϩ)RNA virus molecular clones in general. An infectious clone is assembled as "infectious DNA," and expression of problem regions present in the viral cDNA is prevented during propagation in E. coli by insertion of short introns. To demonstrate the feasibility of this approach, a highly unstable Japanese encephalitis flavivirus infectious clone has been successfully converted into a remarkably stable infectious DNA construct with the specific infectivity of 10 6 pfu/g in cell culture. The proposed strategy may be useful in the design of self-amplifying gene therapy vectors and development of new immunization methodologies, and could facilitate creation of molecular repositories of existing viral vaccines.
INTRODUCTION
Infectious clone methodology, which allows direct manipulation of viral genomes, is a highly valuable tool of modern experimental virology. However, its use and practical importance are often limited due to instability of viral genome-encoding plasmids (viral infectious clones) during propagation in E. coli. The problem is especially manifested in (ϩ)RNA viruses. As a consequence, infectious clones for some viruses are either impossible to assemble, or once assembled, are very difficult to maintain in E. coli due to their predisposition to spontaneous rearrangements and/or to acquisition of stabilizing mutations. One plausible explanation is that such instability results from unanticipated expression of viral cDNA encoding products toxic to the bacterial host. While stable infectious clones for some viruses have been reported (Boyer and Haenni, 1994; Khromykh and Westaway, 1994; Meyers et al., 1996; Geigenmuller et al., 1997) , similar constructs for other viruses exhibit acceptable stability only after assembly in low copy number vectors (Gritsun and Gould, 1998; Gualano et al., 1998; Mendez et al., 1998; Hurrelbrink et al., 1999; Almazan et al., 2000) . For certain viruses more sophisticated procedures have been used for assembly of infectious clone cDNA templates in order to circumvent the instability problem, such as ligation in vitro (Sumiyoshi et al., 1992; Kapoor et al., 1995) , long high-fidelity PCR (Campbell and Pletnev, 2000) , or a combination of both (Herold et al., 1998) . Use of nonbacterial cloning systems (Polo et al., 1997) has been reported as well.
Due to the infectious nature of (ϩ)RNA virus genomes, delivery of (ϩ)RNA transcribed from corresponding viral genome cDNA templates into susceptible cells initiates the viral replication cycle. According to the established practice, (ϩ)RNA viruses are recovered from infectious clones after transfection of synthetic RNA into susceptible cells. This approach also has been proven successful in vivo using synthetic RNA representing genomes of infectious viruses (Gritsun and Gould, 1995; Mandl et al., 1998) , as well as recombinant alphavirus replicons (Zhou et al., 1994; Fleeton et al., 1999; Leitner et al., 1999) . Although as little as 1 ng of infectious virus RNA (Mandl et al., 1998) or 100 ng of recombinant replicon RNA elicited antigen-specific responses upon inoculation in mice, the vulnerability of RNA to degradation undermines the practical importance of this approach. Perhaps for this reason, a DNA/RNA layered approach (Herweijer et al., 1995; Dubensky et al., 1996) has been developed, in which genomic RNA is made in situ by nuclear transcription of viral genome cDNA templates from eukaryotic promoters in cells transfected with correspondingly engineered plasmid DNA, thus leading to initiation of viral RNA replication. However, despite many advantages of the DNA-based approach, only a few examples of infectious DNA for animal viruses have been reported (Semler et al., 1984; Herweijer et al., 1995; Dubensky et al., 1996; Beard et al., 1999) . This approach has found a broader use in the field of plant viruses (reviewed in Boyer and Haenni, 1994) . The instability problem likely represents a major obstacle impeding development of infectious DNA constructs for other (ϩ)RNA viruses. Indeed, if unanticipated expression of viral genome segments in E. coli serves as a chief factor leading to destabilization of plasmids, eukaryotic promoters will only exacerbate its detrimental effects. Substantial transcriptional activity of both viral and cellular eukaryotic promoters has been demonstrated in E. coli (Davis and Huang, 1988; Antonucci et al., 1989) .
We have devised a new strategy, which circumvents the problem of infectious clone instability in E. coli. The proposed strategy is based on the differences in RNA processing between prokaryotes and eukaryotes and allows one to exploit benefits of the infectious DNA methodology. Japanese encephalitis (JE) virus belongs to the Flaviviridae family of (ϩ)RNA viruses, which also includes yellow fever (YF), West Nile, tick borne encephalitis, dengue, and hepatitis C viruses. Flaviviruses, in particular JE (Sumiyoshi et al., 1992) and YF (Rice et al., 1989) , represent the most striking examples of highly unstable infectious clones, which have been composed by in vitro ligation. By creating a remarkably stable construct containing the JE genome under control of the strong cytomegalovirus promoter (CMVp/e), we demonstrate the feasibility of our approach for the design of stable infectious clones. Direct transfection of infectious JE DNA constructs into BHK cells leads to prompt initiation of productive virus replication, greatly simplifying virus recovery. We believe that the proposed scheme may find a broad use in the design of stable infectious clones of other (ϩ)RNA viruses.
RESULTS
Two original JE plasmids, pM343 and pH756, encoding roughly two halves of the JE virus genome have been described (Sumiyoshi et al., 1992) . The former plasmid was unstable in E. coli, and exhibited a high propensity for rearrangements. Interestingly, spontaneous "large colony size" mutants of pM343, isolated by us and reported earlier (Sumiyoshi et al., 1992) , often contained nonsense mutations at the end of E gene. Using repaired pM343 (designated pT7JE5Ј) and a derivative of pH756 (designated pJE3Ј/Asp), the full-length JE clone (designated pT7JE/Asp) has been assembled in pBR322. Synthetic RNA made with T7 RNA polymerase was infectious, and the recovered virus was similar to the parent JaOArS982 strain by several criteria (V. Yamshchikov, unpublished) . To our knowledge, this is the first successful attempt to assemble a full infectious clone of JE virus in a bacterial plasmid; a complete description of this study will be reported elsewhere. In this report, the virus recovered from the pT7JE/Asp clone will be referred to as the parent virus. Compared to pT7JE5Ј, pT7JE/Asp displayed much higher predisposition to rearrangements and very poor growth characteristics upon propagation in E. coli.
Design of stable JE infectious DNA
Initial attempts to assemble the JE 5Ј-half genome cassette downstream from CMVp/e failed because only plasmids with extensive deletions were recovered. Presumably, the instability of the plasmids was caused by CMVp/e, since substantial transcriptional activity in E. coli has been reported for this and other eukaryotic promoters (Davis and Huang, 1988; Antonucci et al., 1989) . Earlier we noticed that nonsense mutations upstream from hydrophobic domains present at the end of E and beginning of NS1 (Fig. 1a) often resulted in stabilization of the pT7JE5Ј plasmid. We intentionally introduced stop codons upstream from this region as part of an intron. A site for Ecl136 II, GAG/CTC, located at pos. 2215 upstream from the problem region, was used for insertion of a 132-bp chimeric intron producing sequence 5Ј . . .GAGGT. . .AGCTC. . .3Ј (an abbreviated sequence of the intron is in bold). Precise excision of the intron due to splicing in mammalian cells would restore the original restriction site, thus providing a simple means to monitor processing of transcripts. Although the resulting pT7JE5Ј(i2217) plasmid appeared stable, replacement of the T7 promoter with CMVp/e caused substantial destabilization of the construct since the majority of recovered plasmids contained various rearrangements. One of pCMVp/eJE5Ј(i2217) plasmids appeared to contain the JE fragment of the correct length; however, transfection of this plasmid into BHK cells did not result in JE-specific cell fluorescence (Fig. 3, panel a-1) . A 5-nt frameshift deletion was found upstream from the region encoding the prM signal sequence, suggesting that expression of this genome region may have caused destabilization. To alleviate this problem, a second copy of the same intron was inserted in the Ecl136 II site, created at pos. 354 upstream from this genome region (Fig. 1a) . The resulting pCMVp/eJE5Ј(i356i2217) construct had excellent sta- (Rice, 1996) . KpnI is an isoshizomer of Asp718. Vertical bars mark gene boundaries, and thicker vertical bars designate hydrophobic protein domains. Pos. 356 and 2217 of intron (i) insertion are indicated. (b) Arrangement of the CMVp/e transcription start (arrow) and beginning of the JE genome (in bold). The TATA element is boxed (Thomsen et al., 1984) . bility and growth characteristics, despite the presence of the direct repeat. Cells transfected with this plasmid showed bright JE-specific fluorescence (Fig. 3 , panel a-2), indicating efficient formation of JE antigens. Interestingly, a plasmid without i2217 appeared much less stable. However, we isolated unperturbed pCMVp/ eJE5Ј(i356), which also produced bright JE-specific cell fluorescence upon transfection (Fig. 3, panel a-3) . The CMVp/eJE5Ј(i356i2217) and CMVp/eJE5Ј(i356) cassettes were joined with the JE3Ј/Asp fragment representing the second half of the JE genome in order to assemble full genome JE cDNA under transcriptional control of CMVp/e. The plasmid containing two introns produced uniformly round, large colonies upon transformation in E. coli. In contrast, the single intron plasmid always produced heterogeneous colonies, indicating a high tendency for rearrangements (Polo et al., 1997) . The JE insert in pCMVp/eJE(i356i2217) was completely sequenced, and no changes were found when compared to the original pT7JE/Asp construct. No changes were found when the plasmid was sequenced again after six sequential transformation-isolation cycles in E. coli HB101, thus attesting to the excellent stability of the construct. In order to ensure defined termination and polyadenylation of in vivo transcripts, the bovine growth hormone transcription termination and polyadenylation signal (BGHTT) was inserted at the 3Ј-end of the JE genome in both constructs, resulting in pCMVp/eJE(i356i2217)BGHTT and pCMVp/eJE(i356)BGHTT (Figs. 1a and 1b) .
Thus, by suppressing deleterious expression of viral genome regions in E. coli at the level of translation, we have converted the highly unstable viral infectious clone into a remarkably stable construct controlled by a eukaryotic promoter. Based on indirect immunofluorescence of the half-genome constructs, intron sequences were recognized in eukaryotic cells and appeared to be precisely removed from the primary transcripts, resulting in synthesis of viral antigens.
Characterization of in vivo transcripts
Initiation and termination of in vivo transcripts was analyzed using a model plasmid pCMVp/e5Ј⌬3ЈBGHTT. Gel-purified products of nested PCR obtained in RLM-RACE assays, as described under Materials and Methods, were sequenced directly with JE-specific primers. The 5Ј-end sequence of the JE genome (GenBank No. M18370) was clearly readable up to its very first nucleotide, with the sequence ambiguity commencing afterward. This indicated that the majority of transcripts included the complete 5Ј-untranslated region, and certain infidelity of transcription initiation resulted in addition of only a few nucleotides upstream from the beginning of JE genome. We did not study this in more detail.
To determine if transcription termination occurs according to the designed scheme, total RNA from cells transfected with pCMVp/e5Ј⌬3ЈBGHTT was analyzed in an adapted 3Ј-end assay (Salles et al., 1999) , as described under Materials and Methods. Isolated RT-PCR fragment contained the complete 3Ј-terminus of the JE genome (GenBank No. M18370), followed by the 5Ј-proximal 137 nt of BGHTT up to the polyadenylation site (Woychik et al., 1982) and including a poly(A)tail, thus confirming that transcription termination and polyadenylation were directed by BGHTT as expected. The length of the poly(A) tail has not been determined.
Splicing of primary transcripts was studied in cells transiently transfected with the half-genome cassettes pCMVp/eJE5Ј(i2217) and pCMVp/eJE5Ј(i356i2217). Using primers flanking the i2217 site of intron insertion, a fragment was detected by RT-PCR analysis of total RNA isolated from cells transfected with pCMVp/eJE5Ј(i2217) (Fig. 2a, lane 3) , which was of the same size as the 364-bp fragment amplified from the original pT7JE5Ј (lane 2). The 496-bp intron-containing fragment (lane 1) was not detected. The presence of the Ecl136 II site (lane 4) evidenced precise removal of the intron and hence restoration of the ORF. This conclusion was further confirmed by sequence analysis of this fragment. Total RNA isolated from cells transfected with pCMVp/ eJE5Ј(i356i2217) was also analyzed by RT-PCR with primers flanking the i356 site of the intron insertion. Again, an amplification product originating from spliced transcripts, i.e., 943 bp rather than 1075 bp long, was detected (Fig. 2b, lane 3) . The fragment also contained the Ecl136 II site (lane 4), evidencing precise excision of the intron and ORF restoration. We confirmed this by com- plete sequencing of the fragment. We were not able to detect alternative splicing for this construct (i.e., the donor site of the first intron to the acceptor site of the second intron resulting in deletion of a 1860-bp fragment of the JE genome) since a 2330-bp fragment rather than a 470-bp fragment was identified with primers flanking the i356 and i2217 sites (lane 5). This is consistent with the linear scanning model of splice site selection (Lang and Spritz, 1983; Smith et al., 1989) . This fragment was also completely sequenced.
Thus, defined termination of transcription, polyadenylation, and correct splicing of transcripts with restoration of the viral ORF have been observed upon transfection of the model constructs into eukaryotic cells. Although transcripts were heterogeneous at their 5Ј-ends, some correctly initiated transcripts that could launch a productive infectious cycle were apparently present.
Transfection of infectious DNA initiates the viral replication cycle
Synthesis of JE-specific antigens in transfected cells was monitored by indirect immunofluorescence, which provided a functional test for ORF integrity. Proper folding of flavivirus structural proteins depends on activity of the viral protease (Mason et al., 1991; Yamshchikov and Compans, 1993) . Since the protease domain of NS3 was encoded at the end of the JE5Ј cassettes, efficient formation of JE antigens would attest to both correct splicing and the presence of the uninterrupted ORF through the entire transcript. Indeed, cells transfected with pCMVp/eJE5Ј(i356i2217) were highly antigen-positive (Fig. 3, panel a-2 ). In contrast, no JE-specific fluorescence was detected in cells transfected with the abovedescribed frameshift mutant of pCMVp/eJE5Ј(i2217) (Fig.  3, panel a-1) , despite correct splicing of the transcript.
Transfection with pCMVp/eJE(i356i2217)BGHTT also produced intensely fluorescent cells, which rapidly increased in number with time until all cells in the monolayer became JE-positive (Fig. 3, panel b) . This indicated formation of infectious virus and spread of infection. To confirm the immunofluorescence data, we investigated synthesis of JE-specific proteins and RNA in cells transfected with pCMVp/eJE(i356i2217)BGHTT. The same sets of JE-specific proteins were immunoprecipitated with JEspecific antiserum from both lysates of transfected cells and cells infected with the parent virus (Fig. 4a) . Synthesis of viral proteins was readily detectable at 5 h after DNA-cell contact, and increased progressively during incubation. Accordingly, increasing amounts of JE-specific RNA were detected by ribonuclease protection assay using a probe complementary to the first 175 nt of the JE genome RNA (Fig. 4b) .
Finally, we have isolated infectious virus from cells transfected with plasmids containing full JE genome cDNA cassettes. Figure 5a shows virus accumulation in the media sampled at various time points after transfection with these DNA. In parallel experiments, all constructs produced virus with similar accumulation rates. We also determined specific infectivities of DNA constructs by transfecting serially diluted plasmids and observing plaque formation after incubation of transfected cells under semisolid overlays. For the same construct, specific infectivities varied substantially depending on transfection reagents used (see also Fig. 4b ). The highest values observed with SuperFect (Qiagen) were in the range 0.1-1 ϫ 10 6 pfu/g of plasmid DNA, with no significant differences between plasmids containing one or two introns. Interestingly, we also did not observe a substantial divergence between plasmids pCMVp/ eJE(i356i2217)BGHTT and pCMVp/eJE(i356i2217), although the former had the defined termination and polyadenylation signal. In the latter, the termination and polyadenylation signal(s) probably was provided by the vector. We did not investigate this question in detail.
Thus, all full-genome JE cDNA constructs controlled by the eukaryotic promoter initiated the virus infectious cycle directly upon transfection of DNA into cells. To our knowledge, this is the first report describing the design of a flavivirus infectious DNA construct.
Characterization of the recovered virus
As evidenced in Fig. 6a , virus recovered from pCMVp/ eJE(i356i2217)BGHTT produced plaques similar to those of the parent virus. Accordingly, both viruses produced identical growth curves (Fig. 5b) , thus corroborating results of plaque assays. A possibility of cross-contamination was excluded since the Ecl136 II site at pos. 354 was present in the genome of the recovered virus (Fig. 6b,  lane 4) , compared to the parent virus (lane 2). This was confirmed by sequencing through the region adjacent to this site.
We have further determined whether genomic RNA of the recovered virus possesses the authentic 5Ј-and 3Ј-ends. Total RNA from cells infected with either of the viruses was analyzed in comparison with uncapped synthetic RNA prepared with T7 polymerase from pT7JE5Ј. Reverse transcriptase extension products of a primer complementary to pos. 80-100 of the JE genome are shown in Fig. 6c , alongside the DNA sequencing ladder prepared from pCMVp/e5Ј⌬3ЈBGHTT using the same primer. In the T7JE5Ј construct, the T7 transcription start is engineered to the beginning of the JE genome; accordingly, the major extension product terminated at the 5Ј-terminal A (lane 3). Slight infidelity of transcription initiation by T7 RNA polymerase may have accounted for the minor presence of longer and shorter extension fragments. Major extension products of the same length were observed for both viruses (lanes 1 and 2). Both were longer by one nucleotide, which likely resulted from copying the cap structure by reverse transcriptase (Dubensky et al., 1996) . The sequence at the JE RNA 5Ј-end was determined using a RLM-RACE kit (Ambion) and was found to be identical for both viruses. Sequence at the 3Ј-end of JE RNA was determined using the adapted RACE-PAT assay (Salles et al., 1999) after polyadenylation of total RNA from infected cells in the presence of poly(A) polymerase, and was also found to be identical for both viruses. Finally, two cDNA fragments covering the entire viral genome were obtained by RT-PCR of total RNA from cells infected with the recovered virus. These fragments were purified and completely sequenced. No differences, except for the two silent mutations introduced to create the Ecl136 II site at pos. 354, were found, when compared to the genome sequence of the parent virus.
The above data confirmed that the virus recovered from pCMVp/eJE(i356i2217)BGHTT was identical to the parent virus, in both phenotype and genotype (except for the two mutations).
DISCUSSION
Despite benefits associated with use of infectious DNA constructs, only a few successful applications of this methodology have been reported for a limited set of animal (ϩ)RNA viruses (Semler et al., 1984; Herweijer et al., 1995; Dubensky et al., 1996; Beard et al., 1999) . Characteristically, these examples are either nonenveloped viruses or enveloped viruses containing genes of nonstructural proteins in the beginning of their genomes. In either case, genome regions proximal to a eukaryotic promoter do not encode extensive stretches of hydrophobic amino acids, and this perhaps may account for the stability of reported infectious plasmids during propagation in E. coli. In contrast, representatives of the Flaviviridae family encode structural proteins, most of which are membrane-associated, in the beginning of their genomes. In this case, spurious transcription from eukaryotic promoters likely results in synthesis of products toxic for E. coli, which may serve as a major destabilizing factor preventing design of such plasmids. Indeed, the only flavivirus DNA/RNA layered construct reported to date was designed for a replicon of Kunjin virus (Varnavski et al., 2000) , which did not include the genome region coding for its structural proteins. In addition, as discussed below, the presence of promoter-like sequences inside the viral genome or foreign gene cassettes may further jeopardize the stability of recombinant plasmids in E. coli. To circumvent these problems, we have attempted to take advantage of the major difference in mRNA formation between prokaryotes and eukaryotes by using eukaryotic RNA processing mechanisms as the essential part of the clone stabilization strategy. This approach was conceived from the observation that a single nonsense mutation, presumably preventing synthesis of toxic products, often was sufficient to stabilize the entire construct. Hence, temporary ablation of such deleterious expression at the level of translation by interrupting the ORF, with help of an intron containing stop codon(s), would be beneficial during propagation of recombinant plasmids in E. coli. The intron would effectively block synthesis of toxic products in the bacterial host, even if spurious transcription resulted in formation of mRNA. Nuclear transcription in eukaryotic cells, accompanied by splicing of the primary transcripts, would lead to precise excision of the intron and restoration of the original ORF. For virus infectious clones and viral replicon-based expression vectors, subsequent export of mRNA to cytoplasm and its translation would result in synthesis of viral proteins, which may initiate the viral infectious cycle or replication of vector RNA. Successful implementation of this approach enabled us to design a flavivirus infectious DNA construct for the first time. We believe that this approach in general can be applied to the design of infectious DNA for other viruses and DNAbased viral replicon expression vectors, although its implementation will be unique for each viral genome. Translational blocks may be introduced where spontaneous stabilizing mutations arise during maintenance of instable constructs in E. coli. In pT7JE/Asp, stabilizing mutations often appeared upstream from the E stoptransfer/NS1 signal sequence, despite the presence of two comparable hydrophobic domains upstream from this region. The T7 promoter itself is not transcriptionally active in E. coli; perhaps, spurious transcription was initiated from a prokaryotic promoter-like sequence located somewhere in the E gene. Indeed, complete stabilization of the T7JE/Asp clone was achieved by the single intron insertion at i2217, probably because it prevented expression of the problem genome region at the level of translation. Replacement of the T7 promoter with CMVp/e, transcriptional activity of which in E. coli has been reported (Davis and Huang, 1988; Antonucci et al., 1989) , resulted in destabilization of the JE5Ј(i2217) cassette. Accordingly, the stabilizing mutation now has been found upstream from the prM signal sequence, and insertion of a second copy of the intron upstream from this region has resulted in complete stabilization of the construct. Removal of the intron at i2217 again destabilized the plasmid, suggesting initiation of spurious transcription from an upstream element. The infectious clone for YF virus also was unstable under control of the bacteriophage promoter (Rice et al., 1989) , suggesting the existence of an internal promoter-like sequence(s) in the YF genome. For a recently reported coronavirus infectious clone (Almazan et al., 2000) , destabilizing sequences found inside the virus genome might also indicate the existence of such elements. It would be interesting to test whether YF and coronavirus infectious clones can be substantially stabilized by inserting temporary translational blocks upstream from the problem genome regions.
A possible problem for implementation of the proposed approach is associated with potential existence of cryptic splice sites in viral RNA genomes (Shiu et al., 1997) . Although we found several such potential sites in the JE genome, this did not appear to have a substantial impact on the functional properties of designed infectious DNA constructs. We were unable to detect alternative splicing for the construct containing two introns. However, this may be explained by a low sensitivity of the protocols used. On the other hand, no significant difference was found in the specific infectivities of constructs containing one intron and two introns, and both plasmids produced virus with identical accumulation rates. Assuming that roughly 1 g equals 1 pmol for a 1500-bp DNA fragment, and assuming that theoretically 1 molecule of infectious DNA per cell is enough to initiate the infectious cycle, the specific infectivity of 10 6 pfu/g that we have observed is about four orders of magnitude less than the theoretically possible value for a 16,000-bp plasmid. While protocols affording higher transfection efficiencies may increase the specific infectivity of the constructs, we cannot exclude the possibility that alternative splicing may have affected the specific infectivity. Although no deleterious splicing was detected even with the large coronavirus infectious DNA clone (Almazan et al., 2000) , this may not be the case for other virus constructs, and certain efforts such as mutagenesis might be required to alleviate the problem.
The current thinking is that the fidelity of the transcript 5Ј-and 3Ј-end formation influences the specific infectivity of synthetic RNA. We cannot exclude the possibility that a higher specific infectivity may be obtained if the 3Ј-end is made authentic to genome RNA, although it is unclear how that could be implemented without affecting RNA processing and transport. For other viruses, which require more precise formation of the RNA ends, this could create another potential problem. A possible rem-edy may be to use a self-cleaved ribozyme in anticipation that some transcripts would be polyadenylated and exported before such self-cleavage takes place, with formation of the authentic 3Ј-end occurring in the cytoplasm (Varnavski et al., 2000) .
We believe that the proposed approach may be useful for further development of infectious DNA methodology. A stable infectious DNA molecular clone easily propagated in E. coli offers a simple, convenient, and costeffective way of maintaining virus and vaccine depositories (Kohara et al., 1986) , thus alleviating to a significant extent the problem of genetic drift associated with propagation of vaccine and viral stocks in eukaryotic hosts. With the advent and rapid development of DNA immunization (Donnelly et al., 1997) , the infectious DNA approach may acquire new meaning that opens new possibilities both in the current immunization practice and in vaccine design. Use of infectious DNA clones derived from existing (ϩ)RNA virus vaccines for immunization directly (Ward et al., 1997) may help underdeveloped countries to pursue more extensive immunization campaigns, since vaccines in the infectious DNA form may be less dependent on maintenance of the cold chain. Furthermore, full genome DNA constructs controlled by eukaryotic promoters together with high transfection efficiency protocols offer the unique possibility of dissociating synthesis and processing of viral proteins from replication of viral RNA. Studies that seek to evaluate the feasibility of this methodology for the design of new vaccine candidates based on pseudolethal viral mutants are currently in progress.
MATERIALS AND METHODS

Cells and viruses
BHK (Bredenbeek et al., 1993) and Vero (ATCC CRL-1586) cells were maintained at 37°C in humidified atmosphere containing 5% CO 2 in DMEM (GIBCO-BRL) containing 5% FCS (Hyclone) and 1ϫ antibiotic-antimycotic mixture (GIBCO-BRL). Stocks of both the wild-type JE virus (strain JaOArS982 (Sumiyoshi et al., 1987) ) and the JE viruses recovered from infectious clones were prepared on Vero cells. All work with infectious material was performed under Biosafety Level 3 containment.
Plasmid construction
DNA was manipulated using standard procedures (Sambrook et al., 1989) with commercially available enzymes. Throughout the study, NIH Guidelines for Research involving Recombinant DNA Molecules were followed. E. coli strain HB101 (F Ϫ ⌬(gpt-proA)62 leuB6 supE44 ara-14 galK2 lacY1 ⌬(mcrC-mrr) rpsL20(Str r ) xyl-5 mtl-1 recA13) was used for cloning and maintenance of recombinant constructs. Sequencing of cDNA fragments and plasmids was done using an ABI 310 Genetic Analyzer (PE Applied Biosystems, Foster City, CA).
The pT7JE5Ј plasmid containing the 5Ј-half of JE (strain JaOArS982) genome cDNA, pos. 1-5576, under control of the T7 promoter was derived from pM343 (Sumiyoshi et al., 1992) by replacement of the HpaI-SacI (pos. 1814-2215) fragment containing a single nucleotide deletion at pos. 2023 with the similar fragment amplified by RT-PCR from JE genomic RNA. The pJE3Ј/Asp plasmid containing the 3Ј-half of JE genome cDNA, pos. 5576-10960, was derived from pH756 (Sumiyoshi et al., 1992) by inverting the JE fragment relative to the origin of replication in pBR322 with simultaneous replacement of the SalI site at the JE 3Ј-end with the Asp718 (abbreviated here to Asp; also created in pBR322 in place of ClaI) by linker addition. The pT7JE/Asp infectious clone was assembled from pT7JE5Ј and pJE3Ј/Asp between SalI and Asp718 sites in pBR322 (Fig. 1a) . The CMVp/e-5ЈJE junction (Fig.  1b) was created by overlapping PCR from pCIneo (pos. 6-744, Promega, Madison, WI) with addition of a SalI site and from JE cDNA (pos. 1-943), and was used as a SalI-MluI fragment. The intron was amplified from pCIneo (pos. 890-1022) and inserted by blunt-end ligation into Ecl136 II sites at pos. 354 and pos. 2215 (Fig. 1a) . The former was created by PCR-directed silent mutagenesis (A3G and T3C, pos. 356 and 358). The PmeI-MluI fragment of JE cDNA, which included both copies of the intron, replaced the corresponding fragment in pT7JE5Ј. The pCMVp/eJE5Ј(i356i2217) and pCMVp/eJE5Ј(i356) plasmids were obtained after subsequent exchange of the SalI-MluI fragments. The full genome JE constructs pCMVp/eJE(i356i2217) and pCMVp/eJE(i356) were created by addition of the 3Ј-half of JE cDNA from pJE3Ј/Asp. A 264-bp Ecl136 II-PvuII BGHTT fragment from pcDNA3 (pos. 1021-1286, Invitrogen, San Diego, CA) was inserted into the filled-in Asp718 site at the end of the JE cassette in both plasmids producing pCMVp/eJE(i356i2217)BGHTT and pCMVp/eJE(i356)BGHTT.
For mapping of the 5Ј-and 3Ј-ends of primary transcripts, pCMVp/e5Ј⌬3ЈBGHTT was created by deleting a middle MluI fragment (pos. 929-8162) of the JE genome. For the ribonuclease protection assays (RPA), a JE cDNA fragment (pos. 1-175) was subcloned into pGEM3 (Promega) to prepare the negative strand probe by run-off transcription of the linearized template from the T7 promoter.
Isolation and analysis of RNA
Total RNA was isolated with the RNeasy Mini Kit (Qiagen, Chatsworth, CA) and DNase treatment according to the manufacturer. RNA was quantified assuming that 1 A 260 equals 40 g/ml. Prior to RT-PCR assays, RNA was again treated with RNase-free DNase (Sigma, St. Louis, MO) in the presence of 1 mM MgCl 2 . DNase was inactivated at 65°C (10 min). The RT-PCR kit (Promega) and the RPA II kit (Ambion, Austin, TX) were used for the corresponding assays. The JE-specific RNA probe for RPA was prepared using [ 32 P]UTP (800 Ci/mmol; NEN, Boston, MA) and the MAXIscript kit (Ambion) according to the manufacturer. Two micrograms of total RNA per sample was used for RT-PCR and RPA.
The sequence at the 5Ј-end of the primary transcripts and JE viral RNA was determined using the RLM-RACE kit (Ambion) according to the manufacturer's protocol. Briefly, 5 g of total RNA from cells transfected with pCMVp/e5Ј⌬3ЈBGHTT or virus-infected cells was dephosphorylated with alkaline phosphatase, treated with tobacco acid pyrophosphatase to remove the 5Ј-cap structure, and then ligated to a supplied RNA linker in the presence of RNA ligase. Following nested RT-PCR using two sets of RNA linker-specific and JE-specific primers, a gel-purified fragment was sequenced.
The 3Ј-end sequences of the primary transcripts and of JE viral RNA were determined using an adapted RACE-PAT assay (Salles et al., 1999) . For transcripts, 3-5 g of total RNA from transfected cells was used; for viral RNA, the same amount of total RNA from infected cells prior to the assay was polyadenylated in the presence of poly(A) polymerase according to the manufacturer (Epicentre Technologies, Madison, WI). Following nested RT-PCR, gel-purified fragments were sequenced.
Analysis of primary transcript splicing and characterization of viral RNA were done by RT-PCR using direct primers corresponding to pos. 1-25 and 1966-1987 , and reverse primers complementary to pos. 919-943 and 2306-2330 of the JE genome.
Detection and analysis of viral proteins
Indirect immunofluorescence assays were used for detection of JE antigens in transfected cells. Cell monolayers grown on glass coverslips were fixed by 5% acetic acid in methanol at Ϫ20°C for 20 min, washed with D-PBS (GIBCO-BRL, Gaithersburg, MD), and incubated with 1:100 dilution of JE immune mouse ascites fluid (AF, ATCC VR-1259 AF) in D-PBS for 1 h at ambient temperature, followed by fluorescein-conjugated goat antimouse IgG (GIBCO-BRL) at 1:100 dilution in D-PBS. Immunoprecipitation of JE proteins from transfected cells using AF and electrophoretic analysis of samples were carried out as described earlier (Yamshchikov and Compans, 1993) .
Transfection, metabolic labeling, and virus assays
Transfection of BHK with plasmid constructs was performed using SuperFect (Qiagen) and Fugene6 (Roche, Indianapolis, IN) reagents according to the manufacturers. Cells (2 ϫ 10 5 ) were transfected with 2 g of DNA for 1-3 h, washed twice with D-PBS, and incubated in the growth medium for specified time periods. Prior to labeling, cells were starved for 1 h in the Met-deficient MEM (GIBCO-BRL), labeled for 1 h with 100 Ci of the [
35 S]-Labeling Mix (NEN), and then chased in the growth medium for 3 h before harvesting as described earlier (Yamshchikov and Compans, 1993) .
To determine virus growth characteristics, 2 ϫ 10 5 BHK cells in six-well plates were either transfected with 1 g of infectious plasmids or infected with 100 pfu of viruses. Following 3-h transfection or 1-h virus adsorption periods, cells were washed with D-PBS and incubated in the growth medium for 4 days. At indicated intervals, samples of media were collected and frozen. Titers of virus samples were determined by plaque assay of serial 10-fold virus dilutions on BHK cells. Following 1-h adsorption, virus inoculum was removed; cell monolayers were washed once with D-PBS and overlaid with DMEM containing 2% FCS and 1% methylcellulose (Sigma). Cells were incubated for 3-5 days, the overlay was removed, and plaques were visualized by staining with 1% crystal violet (Sigma) in 70% methyl alcohol. The same procedure was used for plaque assays following 3-h transfection with serial 10-fold dilutions of plasmids in the presence of 1 g of carrier DNA (pBR322).
